These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 38713628)
1. THEMIS promotes T cell development and maintenance by rising the signaling threshold of the inhibitory receptor BTLA. Mélique S; Vadel A; Rouquié N; Yang C; Bories C; Cotineau C; Saoudi A; Fazilleau N; Lesourne R Proc Natl Acad Sci U S A; 2024 May; 121(20):e2318773121. PubMed ID: 38713628 [TBL] [Abstract][Full Text] [Related]
2. B and T lymphocyte attenuator-mediated signal transduction provides a potent inhibitory signal to primary human CD4 T cells that can be initiated by multiple phosphotyrosine motifs. Chemnitz JM; Lanfranco AR; Braunstein I; Riley JL J Immunol; 2006 Jun; 176(11):6603-14. PubMed ID: 16709818 [TBL] [Abstract][Full Text] [Related]
3. THEMIS enhances TCR signaling and enables positive selection by selective inhibition of the phosphatase SHP-1. Choi S; Warzecha C; Zvezdova E; Lee J; Argenty J; Lesourne R; Aravind L; Love PE Nat Immunol; 2017 Apr; 18(4):433-441. PubMed ID: 28250424 [TBL] [Abstract][Full Text] [Related]
4. BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Watanabe N; Gavrieli M; Sedy JR; Yang J; Fallarino F; Loftin SK; Hurchla MA; Zimmerman N; Sim J; Zang X; Murphy TL; Russell JH; Allison JP; Murphy KM Nat Immunol; 2003 Jul; 4(7):670-9. PubMed ID: 12796776 [TBL] [Abstract][Full Text] [Related]
6. Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2. Gavrieli M; Watanabe N; Loftin SK; Murphy TL; Murphy KM Biochem Biophys Res Commun; 2003 Dec; 312(4):1236-43. PubMed ID: 14652006 [TBL] [Abstract][Full Text] [Related]
7. PD-1 and BTLA regulate T cell signaling differentially and only partially through SHP1 and SHP2. Xu X; Hou B; Fulzele A; Masubuchi T; Zhao Y; Wu Z; Hu Y; Jiang Y; Ma Y; Wang H; Bennett EJ; Fu G; Hui E J Cell Biol; 2020 Jun; 219(6):. PubMed ID: 32437509 [TBL] [Abstract][Full Text] [Related]
8. Quantitative Interactomics in Primary T Cells Provides a Rationale for Concomitant PD-1 and BTLA Coinhibitor Blockade in Cancer Immunotherapy. Celis-Gutierrez J; Blattmann P; Zhai Y; Jarmuzynski N; Ruminski K; Grégoire C; Ounoughene Y; Fiore F; Aebersold R; Roncagalli R; Gstaiger M; Malissen B Cell Rep; 2019 Jun; 27(11):3315-3330.e7. PubMed ID: 31189114 [TBL] [Abstract][Full Text] [Related]
10. Dual inhibition of BTLA and PD-1 can enhance therapeutic efficacy of paclitaxel on intraperitoneally disseminated tumors. Sun WZ; Lin HW; Chen WY; Chien CL; Lai YL; Chen J; Chen YL; Cheng WF J Immunother Cancer; 2023 Jul; 11(7):. PubMed ID: 37463789 [TBL] [Abstract][Full Text] [Related]
11. Themis controls thymocyte selection through regulation of T cell antigen receptor-mediated signaling. Fu G; Vallée S; Rybakin V; McGuire MV; Ampudia J; Brockmeyer C; Salek M; Fallen PR; Hoerter JA; Munshi A; Huang YH; Hu J; Fox HS; Sauer K; Acuto O; Gascoigne NR Nat Immunol; 2009 Aug; 10(8):848-56. PubMed ID: 19597499 [TBL] [Abstract][Full Text] [Related]
12. Themis, a T cell-specific protein important for late thymocyte development. Lesourne R; Uehara S; Lee J; Song KD; Li L; Pinkhasov J; Zhang Y; Weng NP; Wildt KF; Wang L; Bosselut R; Love PE Nat Immunol; 2009 Aug; 10(8):840-7. PubMed ID: 19597498 [TBL] [Abstract][Full Text] [Related]
14. Hepatic expansion of virus-specific CD8 Wang H; Wu B; Li L; Hu L; Lin J; Jiang C; Cai G; Shen Q Cell Immunol; 2017 Jan; 311():36-45. PubMed ID: 27743606 [TBL] [Abstract][Full Text] [Related]
15. Themis-associated phosphatase activity controls signaling in T cell development. Mehta M; Brzostek J; Chen EW; Tung DWH; Chen S; Sankaran S; Yap J; Rybakin V; Gascoigne NRJ Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11331-E11340. PubMed ID: 30413615 [TBL] [Abstract][Full Text] [Related]
16. Molecular features underlying differential SHP1/SHP2 binding of immune checkpoint receptors. Xu X; Masubuchi T; Cai Q; Zhao Y; Hui E Elife; 2021 Nov; 10():. PubMed ID: 34734802 [TBL] [Abstract][Full Text] [Related]
17. PD-L1/BTLA Checkpoint Axis Exploited for Bacterial Immune Escape by Restraining CD8+ T Cell-Initiated Adaptive Immunity in Zebrafish. Hu CB; Huang C; Wang J; Hong Y; Fan DD; Chen Y; Lin AF; Xiang LX; Shao JZ J Immunol; 2023 Sep; 211(5):816-835. PubMed ID: 37486225 [TBL] [Abstract][Full Text] [Related]
18. N-Glycan Branching Regulates BTLA Opposite to PD-1 to Limit T Cell Hyperactivity Induced by Branching Deficiency. Mkhikian H; Zhou RW; Saryan H; Sánchez CD; Balakrishnan A; Dang J; Mortales CL; Demetriou M J Immunol; 2024 Nov; 213(9):1329-1337. PubMed ID: 39269653 [TBL] [Abstract][Full Text] [Related]
19. T cell receptor and cytokine signal integration in CD8 Brzostek J; Gautam N; Zhao X; Chen EW; Mehta M; Tung DWH; Chua YL; Yap J; Cho SH; Sankaran S; Rybakin V; Fu G; Gascoigne NRJ Nat Immunol; 2020 Feb; 21(2):186-198. PubMed ID: 31932808 [TBL] [Abstract][Full Text] [Related]
20. B and T lymphocyte attenuator is highly expressed on CMV-specific T cells during infection and regulates their function. Serriari NE; Gondois-Rey F; Guillaume Y; Remmerswaal EB; Pastor S; Messal N; Truneh A; Hirsch I; van Lier RA; Olive D J Immunol; 2010 Sep; 185(6):3140-8. PubMed ID: 20693422 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]